UK markets close in 5 hours 40 minutes

TTY Biopharm Company Limited (4105.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
77.600.00 (0.00%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,997,253
5,505,542
5,061,606
4,535,610
4,221,836
Cost of revenue
1,960,554
2,218,466
2,040,108
1,767,630
1,617,062
Gross profit
3,036,699
3,287,076
3,021,498
2,767,980
2,604,774
Operating expenses
Research development
349,817
310,438
353,436
287,595
261,597
Selling general and administrative
1,379,631
1,601,193
1,436,164
1,324,724
1,388,173
Total operating expenses
1,729,448
1,911,631
1,789,600
1,612,319
1,649,770
Operating income or loss
1,307,251
1,375,445
1,231,898
1,155,661
955,004
Interest expense
21,178
35,360
23,154
18,985
19,413
Income before tax
1,500,818
1,419,465
1,408,339
1,087,380
1,201,525
Income tax expense
296,941
300,864
305,249
264,811
222,848
Income from continuing operations
1,203,877
1,118,601
1,103,090
822,569
978,677
Net income
1,193,233
1,128,509
1,094,391
831,894
924,178
Net income available to common shareholders
1,193,233
1,128,509
1,094,391
831,894
924,178
Basic EPS
4.69
-
4.40
3.35
3.72
Diluted EPS
4.69
-
4.40
3.34
3.71
Basic average shares
248,650
-
248,725
248,650
248,650
Diluted average shares
248,997
-
248,725
249,059
249,063